Aligos Therapeutics (ALGS) Stock Price & Financial Analysis
Aligos Therapeutics Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Aligos Therapeutics
What is the current stock price for ALGS?
As of the latest trading session, ALGS stock trades at $5.65. The 52-week range is $4.80–$13.69, with a day range of $5.48–$5.94.
What is the P/E ratio for ALGS?
The P/E ratio (Price-to-Earnings) for ALGS is shown in the Key Statistics section. This valuation metric helps compare Aligos Therapeutics, Inc. to industry peers.
Does ALGS pay dividends?
Aligos Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for ALGS?
Based on 4 analysts, the consensus for ALGS is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.
What is the market cap of ALGS?
Aligos Therapeutics's market capitalization is $58.8M, classifying it as a micro-cap company. Aligos Therapeutics operates in the Healthcare sector within the Biotechnology industry.